An anterior left ventricular lead position is associated with increased mortality and non-response in cardiac resynchronization therapy

Int J Cardiol. 2016 Nov 1:222:157-162. doi: 10.1016/j.ijcard.2016.07.235. Epub 2016 Jul 30.

Abstract

Background: Non-response to cardiac resynchronization therapy (CRT) might be due to insufficient resynchronization as a result of a sub-optimal left ventricular lead positon (LV-LP).

Objective: To evaluate the impact of different LV-LPs on mortality and symptomatic improvement in a large cohort of patients treated with CRT.

Methods: We performed a nationwide cohort study on consecutive patients receiving a CRT device from 1997 to 2012 registered in the Danish pacemaker and ICD register. The LV-LP was defined clockwise in a left anterior oblique (LAO) view and categorized as anterior (≤2 o'clock), lateral (2 to 4 o'clock) or posterior (>4 o'clock), and as basal, mid-ventricular, or apical in a right anterior oblique (RAO) view. Outcomes were all cause mortality and clinical response (improvement in NYHA class). Adjusted hazard ratio (aHR) and odds ratio (aOR) with 95% confidence intervals (CI) were calculated using Cox and logistic regression analysis.

Results: A total of 2594 patients were included. A lateral LV-LP, (aHR 0.77, 95% CI 0.64-0.92, p=0.004), and a posterior LV-LP, (aHR 0.71 95% CI 0.53-0.97, p=0.029) were associated with lower mortality as compared to an anterior LV-LP. A lateral LV-PV was associated with higher clinical response rate as compared to an anterior LV-LP (aOR 1.37, 1.03-1.83, p=0.032). No statistically significant associations were observed between LV-LP in the RAO view and mortality or clinical response.

Conclusion: An anterior left ventricular lead position is associated with increased all-cause mortality and lower clinical response rate in patients treated with CRT and should be avoided.

Keywords: Biventricular pacing; Cardiac resynchronization therapy; Heart failure; Lead position; Pacing.

MeSH terms

  • Aged
  • Cardiac Resynchronization Therapy Devices / adverse effects*
  • Cardiac Resynchronization Therapy* / adverse effects
  • Cardiac Resynchronization Therapy* / methods
  • Cohort Studies
  • Denmark / epidemiology
  • Echocardiography / methods
  • Electrocardiography / methods
  • Female
  • Heart Failure* / diagnosis
  • Heart Failure* / mortality
  • Heart Failure* / physiopathology
  • Heart Failure* / therapy
  • Heart Ventricles* / diagnostic imaging
  • Heart Ventricles* / physiopathology
  • Humans
  • Male
  • Middle Aged
  • Proportional Hazards Models
  • Prosthesis Implantation* / adverse effects
  • Prosthesis Implantation* / methods
  • Prosthesis Implantation* / standards
  • Severity of Illness Index
  • Treatment Outcome